CME.NASDAQCme Group INC

Form 4: CME Group Director Phyllis M. Lockett Reports Stock Acquisition

Sentiment:

SEC Form 4 Filing


Phyllis M. Lockett, a director of CME Group Inc., reported acquiring 748 shares of Class A Common Stock on June 25, 2024, at a price of $194.1 per share.

Summary

  • Phyllis M. Lockett, a director at CME Group Inc., filed a Form 4 with the SEC.
  • The filing reports a transaction that occurred on June 25, 2024.
  • Lockett acquired 748 shares of Class A Common Stock at a price of $194.1 per share.
  • Following the transaction, Lockett directly owns 4,168 shares of CME Group Inc.
  • The acquisition was granted pursuant to the CME Group Director Stock Plan, as amended and restated.

Sentiment

Score: 5

Explanation: The document is a neutral regulatory filing. The sentiment is neither positive nor negative as it simply reports a transaction.

Positives

  • The director's stock acquisition could be interpreted as a positive signal regarding her confidence in the company's future prospects.

Industry Context

Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders. They are closely watched by investors seeking insights into management's perspective on the company's valuation and future performance.

Stakeholder Impact

  • The transaction may have a minor positive impact on shareholder sentiment.

Key Dates

DateDescription
06/25/2024Date of stock acquisition.
06/26/2024Date of signature on the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.